With these advances, we hope to see the Bi-ChTCRs move to the clinic, hoping to generate long-lasting responses and prevent relapses in patients.
@fredhutch.bsky.social @natureportfolio.nature.com @naturecancer.bsky.social
#CancerResearch #Immunotherapy #TCellTherapy #BiChTCR #SyntheticImmunity
@fredhutch.bsky.social @natureportfolio.nature.com @naturecancer.bsky.social
#CancerResearch #Immunotherapy #TCellTherapy #BiChTCR #SyntheticImmunity
March 17, 2025 at 9:22 PM
With these advances, we hope to see the Bi-ChTCRs move to the clinic, hoping to generate long-lasting responses and prevent relapses in patients.
@fredhutch.bsky.social @natureportfolio.nature.com @naturecancer.bsky.social
#CancerResearch #Immunotherapy #TCellTherapy #BiChTCR #SyntheticImmunity
@fredhutch.bsky.social @natureportfolio.nature.com @naturecancer.bsky.social
#CancerResearch #Immunotherapy #TCellTherapy #BiChTCR #SyntheticImmunity
With these advances, we hope to see the Bi-ChTCRs move to the clinic, hoping to generate long-lasting responses and prevent relapses in cancer patients.
@fredhutch.bsky.social
#CancerResearch #Immunotherapy #TCellTherapy #Bi-ChTCR #SyntheticImmunity
@fredhutch.bsky.social
#CancerResearch #Immunotherapy #TCellTherapy #Bi-ChTCR #SyntheticImmunity
March 17, 2025 at 9:15 PM
With these advances, we hope to see the Bi-ChTCRs move to the clinic, hoping to generate long-lasting responses and prevent relapses in cancer patients.
@fredhutch.bsky.social
#CancerResearch #Immunotherapy #TCellTherapy #Bi-ChTCR #SyntheticImmunity
@fredhutch.bsky.social
#CancerResearch #Immunotherapy #TCellTherapy #Bi-ChTCR #SyntheticImmunity
Researchers have developed a T cell therapy that “trains” patients' own immune cells to recognise tumour associated proteins. Anya Alsamaraie explains this approach in BioNews: www.progress.org.uk/t-cell-thera...
#Cancer #TCellTherapy #ClinicalResearch #Health #Paediatrics #BrainCancer
#Cancer #TCellTherapy #ClinicalResearch #Health #Paediatrics #BrainCancer
July 23, 2026 at 10:16 AM
Researchers have developed a T cell therapy that “trains” patients' own immune cells to recognise tumour associated proteins. Anya Alsamaraie explains this approach in BioNews: www.progress.org.uk/t-cell-thera...
#Cancer #TCellTherapy #ClinicalResearch #Health #Paediatrics #BrainCancer
#Cancer #TCellTherapy #ClinicalResearch #Health #Paediatrics #BrainCancer
How do antibodies affect T–cell–target interactions?
With the LIVE T Cell Assay, you can track these effects live:
🟡Immune synapse formation
🔴T cell behavior
🔵Target cell fate
See how your candidates perform in real time, no dyes, no disruption
Watch here: bit.ly/3Ue6JrJ
#TCellTherapy #LiveCellTech
With the LIVE T Cell Assay, you can track these effects live:
🟡Immune synapse formation
🔴T cell behavior
🔵Target cell fate
See how your candidates perform in real time, no dyes, no disruption
Watch here: bit.ly/3Ue6JrJ
#TCellTherapy #LiveCellTech
August 4, 2025 at 12:28 PM
How do antibodies affect T–cell–target interactions?
With the LIVE T Cell Assay, you can track these effects live:
🟡Immune synapse formation
🔴T cell behavior
🔵Target cell fate
See how your candidates perform in real time, no dyes, no disruption
Watch here: bit.ly/3Ue6JrJ
#TCellTherapy #LiveCellTech
With the LIVE T Cell Assay, you can track these effects live:
🟡Immune synapse formation
🔴T cell behavior
🔵Target cell fate
See how your candidates perform in real time, no dyes, no disruption
Watch here: bit.ly/3Ue6JrJ
#TCellTherapy #LiveCellTech
Which CAR-T clone works best?
Don’t rely on endpoints.
Our LIVE T Cell Assay shows real-time, label-free killing efficiency with digital overlays:
🟢 green = healthy
🟠 orange = dead
🎥 Watch 4 clones tested on the same cancer line: bit.ly/40vBvQp
#TCellTherapy #LiveCellImaging #CAR-T
Don’t rely on endpoints.
Our LIVE T Cell Assay shows real-time, label-free killing efficiency with digital overlays:
🟢 green = healthy
🟠 orange = dead
🎥 Watch 4 clones tested on the same cancer line: bit.ly/40vBvQp
#TCellTherapy #LiveCellImaging #CAR-T
July 29, 2025 at 1:35 PM
Which CAR-T clone works best?
Don’t rely on endpoints.
Our LIVE T Cell Assay shows real-time, label-free killing efficiency with digital overlays:
🟢 green = healthy
🟠 orange = dead
🎥 Watch 4 clones tested on the same cancer line: bit.ly/40vBvQp
#TCellTherapy #LiveCellImaging #CAR-T
Don’t rely on endpoints.
Our LIVE T Cell Assay shows real-time, label-free killing efficiency with digital overlays:
🟢 green = healthy
🟠 orange = dead
🎥 Watch 4 clones tested on the same cancer line: bit.ly/40vBvQp
#TCellTherapy #LiveCellImaging #CAR-T
Liquid models need a new lens—and we’ve got it. Nanolive’s LIVE T Cell Assay captures how T cells behave in suspension: real time, no dyes.
🎥 Watch them in action: bit.ly/40vBvQp
#TCellTherapy #LiquidTumors #ImmunoOncology
🎥 Watch them in action: bit.ly/40vBvQp
#TCellTherapy #LiquidTumors #ImmunoOncology
July 28, 2025 at 1:10 PM
Liquid models need a new lens—and we’ve got it. Nanolive’s LIVE T Cell Assay captures how T cells behave in suspension: real time, no dyes.
🎥 Watch them in action: bit.ly/40vBvQp
#TCellTherapy #LiquidTumors #ImmunoOncology
🎥 Watch them in action: bit.ly/40vBvQp
#TCellTherapy #LiquidTumors #ImmunoOncology
#OrcaBio #allogeneiccelltherapy #OrcaT #Tcelltherapy #investigationalallogeneicTcellimmunotherapy #PrecisionTtrial #acutemyeloidleukaemia #acutelymphoblasticleukaemia #highriskmyelodysplasticsyndrome #mixedphenotypeacuteleukaemia #alloHSCT #cGvHD #alloHSCT
pharmatimes.com/news/orca-bi...
pharmatimes.com/news/orca-bi...
Orca Bio’s T-cell therapy shows promise in haematological malignancies - PharmaTimes
The company is preparing to submit the results to the FDA this year
pharmatimes.com
March 20, 2025 at 12:02 PM
A Common Virus Just Got a Lot More Dangerous
A new study reveals that a common strain of HPV can directly cause skin cancer by hijacking our cells—and that fixing the immune system can stop it.
#CancerResearch #HPV #SkinCancerAwareness #Immunotherapy #TCellTherapy
A new study reveals that a common strain of HPV can directly cause skin cancer by hijacking our cells—and that fixing the immune system can stop it.
#CancerResearch #HPV #SkinCancerAwareness #Immunotherapy #TCellTherapy
November 12, 2025 at 6:27 PM
A Common Virus Just Got a Lot More Dangerous
A new study reveals that a common strain of HPV can directly cause skin cancer by hijacking our cells—and that fixing the immune system can stop it.
#CancerResearch #HPV #SkinCancerAwareness #Immunotherapy #TCellTherapy
A new study reveals that a common strain of HPV can directly cause skin cancer by hijacking our cells—and that fixing the immune system can stop it.
#CancerResearch #HPV #SkinCancerAwareness #Immunotherapy #TCellTherapy
Researchers @biomedizin.unibas.ch developed cartilage implants from nasal septum cells, and showed that allowing them to mature for two weeks improved outcomes. 🔬Congratulations to all contributors.
doi.org/10.1126/scit...
#Immunotherapy #CancerImmunology #FusionProtein #PD1IL2v #TCellTherapy
doi.org/10.1126/scit...
#Immunotherapy #CancerImmunology #FusionProtein #PD1IL2v #TCellTherapy
September 18, 2025 at 7:30 AM
Researchers @biomedizin.unibas.ch developed cartilage implants from nasal septum cells, and showed that allowing them to mature for two weeks improved outcomes. 🔬Congratulations to all contributors.
doi.org/10.1126/scit...
#Immunotherapy #CancerImmunology #FusionProtein #PD1IL2v #TCellTherapy
doi.org/10.1126/scit...
#Immunotherapy #CancerImmunology #FusionProtein #PD1IL2v #TCellTherapy
Review Article
Role of CD19 Chimeric Antigen Receptor T Cell Therapy in Idiopathic Inflammatory Myopathies
📖 www.jrheum.org/cgi/content/...
#TCellTherapy #inflammatorymyopathies
Role of CD19 Chimeric Antigen Receptor T Cell Therapy in Idiopathic Inflammatory Myopathies
📖 www.jrheum.org/cgi/content/...
#TCellTherapy #inflammatorymyopathies
June 5, 2025 at 7:49 PM
Review Article
Role of CD19 Chimeric Antigen Receptor T Cell Therapy in Idiopathic Inflammatory Myopathies
📖 www.jrheum.org/cgi/content/...
#TCellTherapy #inflammatorymyopathies
Role of CD19 Chimeric Antigen Receptor T Cell Therapy in Idiopathic Inflammatory Myopathies
📖 www.jrheum.org/cgi/content/...
#TCellTherapy #inflammatorymyopathies
Featured today by @MSKLibrary: Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific dx.doi.org/10.1016/j.xc...
#CancerImmunotherapy #TumorMicroenvironment
#ImmunoOncology #TCellTherapy #Tebentafusp #CD3Engager #ImmuneLandscape #Cancer
#CancerImmunotherapy #TumorMicroenvironment
#ImmunoOncology #TCellTherapy #Tebentafusp #CD3Engager #ImmuneLandscape #Cancer
April 23, 2025 at 4:34 PM
Featured today by @MSKLibrary: Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific dx.doi.org/10.1016/j.xc...
#CancerImmunotherapy #TumorMicroenvironment
#ImmunoOncology #TCellTherapy #Tebentafusp #CD3Engager #ImmuneLandscape #Cancer
#CancerImmunotherapy #TumorMicroenvironment
#ImmunoOncology #TCellTherapy #Tebentafusp #CD3Engager #ImmuneLandscape #Cancer
Stanford has treated its 1st patient with Tecelra. Tecelra is the first FDA-approved engineered TCR therapy, specifically for #SynovialSarcoma. med.stanford.edu/cancer/about... @drbetofmdphd.bsky.social #Tcelltherapy
Stanford infuses first patient with innovative solid tumor therapy
Stanford treated its first patient with Tecelra, a breakthrough engineered T cell receptor therapy that uses a patient’s own immune cells to target cancer.
med.stanford.edu
April 3, 2025 at 4:02 PM
Stanford has treated its 1st patient with Tecelra. Tecelra is the first FDA-approved engineered TCR therapy, specifically for #SynovialSarcoma. med.stanford.edu/cancer/about... @drbetofmdphd.bsky.social #Tcelltherapy
✔ A new autologous T-cell therapy offers hope for children with brain tumors.
🙂 Another encouraging news from Groupe UIG.
Read: lnkd.in/gXsrB66E
#TCellTherapy #AutologousTCells #Immunotherapy #PediatricOncology #BrainTumor #Biotechnology
🙂 Another encouraging news from Groupe UIG.
Read: lnkd.in/gXsrB66E
#TCellTherapy #AutologousTCells #Immunotherapy #PediatricOncology #BrainTumor #Biotechnology
July 18, 2026 at 2:15 PM
✔ A new autologous T-cell therapy offers hope for children with brain tumors.
🙂 Another encouraging news from Groupe UIG.
Read: lnkd.in/gXsrB66E
#TCellTherapy #AutologousTCells #Immunotherapy #PediatricOncology #BrainTumor #Biotechnology
🙂 Another encouraging news from Groupe UIG.
Read: lnkd.in/gXsrB66E
#TCellTherapy #AutologousTCells #Immunotherapy #PediatricOncology #BrainTumor #Biotechnology
What if a new immunotherapy could improve outcomes for some of the most aggressive pediatric brain cancers?
🙂 Another encouraging news from Groupe UIG.
Read: medicalxpress.com/news/2026-06...
#Immunotherapy #TCellTherapy #PediatricCancer #Oncology #Biotechnology
🙂 Another encouraging news from Groupe UIG.
Read: medicalxpress.com/news/2026-06...
#Immunotherapy #TCellTherapy #PediatricCancer #Oncology #Biotechnology
June 30, 2026 at 11:42 AM
What if a new immunotherapy could improve outcomes for some of the most aggressive pediatric brain cancers?
🙂 Another encouraging news from Groupe UIG.
Read: medicalxpress.com/news/2026-06...
#Immunotherapy #TCellTherapy #PediatricCancer #Oncology #Biotechnology
🙂 Another encouraging news from Groupe UIG.
Read: medicalxpress.com/news/2026-06...
#Immunotherapy #TCellTherapy #PediatricCancer #Oncology #Biotechnology
A recent study reports that a new #immunotherapy using autologous #TCellTherapy targeting multiple #TumorAntigens has shown promising safety and clinical effects in a first-in-human phase 1/2 #ClinicalTrial for #PancreaticCancer.
#PancreaticCancerTreatment
#PancreaticCancerTreatment
Autologous T cell therapy targeting multiple antigens shows promise treating pancreatic cancer – BioNews Central
A recent study reports that a new immunotherapy using autologous T cell therapy targeting multiple tumor antigens has shown promising safety and clinical effects in a first-in-human phase 1/2 trial for pancreatic cancer. ...
sbee.link
January 14, 2026 at 12:41 AM
A recent study reports that a new #immunotherapy using autologous #TCellTherapy targeting multiple #TumorAntigens has shown promising safety and clinical effects in a first-in-human phase 1/2 #ClinicalTrial for #PancreaticCancer.
#PancreaticCancerTreatment
#PancreaticCancerTreatment
Personalized T cell therapy shows potential for targeting stable regions of HIV and enhancing immune control.
#HIV #TCellTherapy #ConservedEpitopes #Immunotherapy #HIVResearch
www.nature.com/articles/s41...
#HIV #TCellTherapy #ConservedEpitopes #Immunotherapy #HIVResearch
www.nature.com/articles/s41...
December 23, 2025 at 8:59 PM
Personalized T cell therapy shows potential for targeting stable regions of HIV and enhancing immune control.
#HIV #TCellTherapy #ConservedEpitopes #Immunotherapy #HIVResearch
www.nature.com/articles/s41...
#HIV #TCellTherapy #ConservedEpitopes #Immunotherapy #HIVResearch
www.nature.com/articles/s41...
Targeting #SRSF1 with TN2008 disrupts tumor cell metabolism and enhances CD8+ T cell #AntiTumorImmunity, improving glycolytic reprogramming, effector function, and adoptive #TCellTherapy efficacy. @fudan-university.bsky.social #medsky
#OpenAccess in #STTT: doi.org/10.1038/s413...
#OpenAccess in #STTT: doi.org/10.1038/s413...
October 26, 2025 at 12:30 AM
Targeting #SRSF1 with TN2008 disrupts tumor cell metabolism and enhances CD8+ T cell #AntiTumorImmunity, improving glycolytic reprogramming, effector function, and adoptive #TCellTherapy efficacy. @fudan-university.bsky.social #medsky
#OpenAccess in #STTT: doi.org/10.1038/s413...
#OpenAccess in #STTT: doi.org/10.1038/s413...
#CellTherapy #RegenerativeMedicine #Immunotherapy #AdvancedTherapies #CAR_TCells #GeneTherapy #StemCellResearch #CellAndGeneTherapy #InnovativeMedicine #NextGenTherapies #PrecisionMedicine #Biotechnology #CancerImmunotherapy #TCellTherapy #GeneEditing #PersonalizedMedicine #BiopharmaInnovation
January 10, 2025 at 9:12 PM
#CureCancer #AdvancedTherapies #Biopharma #PrecisionMedicine #CheckpointInhibitors #TCellTherapy #SolidTumorTherapy #HematologicCancers #StemCellResearch #CancerTreatment #TumorTargeting #TranslationalResearch #BiotechRevolution #ImmunoOncology #FutureOfMedicine #BreakthroughScience
November 30, 2024 at 1:35 AM
#CureCancer #AdvancedTherapies #Biopharma #PrecisionMedicine #CheckpointInhibitors #TCellTherapy #SolidTumorTherapy #HematologicCancers #StemCellResearch #CancerTreatment #TumorTargeting #TranslationalResearch #BiotechRevolution #ImmunoOncology #FutureOfMedicine #BreakthroughScience
November 29, 2024 at 5:36 AM